Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11865159 Therapeutic RNA

Patent 11865159 was granted and assigned to Sanofi on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ugur Sahin0

Dmitri G. Wiederschain0

Timothy R. Wagenaar0

Friederike Gieseke0

Christian Hotz0

Date of Patent

January 9, 2024

0

Patent Application Number

172456050

Date Filed

April 30, 2021

0

Patent Citations

US Patent 9205148 Antibodies and other molecules that bind B7-H1 and PD-1

0

US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

0

US Patent 8067227 Viral vectors and the use of the same for gene therapy

0

US Patent 8354509 Antibodies to human programmed death receptor PD-1

0

US Patent 8609089 Compositions of PD-1 antagonists and methods of use

0

US Patent 9987500 Human antibodies to PD-1

0

Patent Primary Examiner

Vanessa L. Ford

0

CPC Code

0

0

0

0

Patent abstract

This disclosure relates to the field of therapeutic RNAs for treatment of solid tumor cancers.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11865159 Therapeutic RNA

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool